iOS 18.6.1 Has Arrived, Here’s What’s New

iOS 18.6.1 brings iPhone-dependent workaround for Series 9, 10, and Ultra 2 owners after 18-month patent dispute.

Annemarije de Boer Avatar
Annemarije de Boer Avatar

By

Our editorial process is built on human expertise, ensuring that every article is reliable and trustworthy. AI helps us shape our content to be as accurate and engaging as possible.
Learn more about our commitment to integrity in our Code of Ethics.

Image Credit: Gadget Review

Key Takeaways

Key Takeaways

  • iOS 18.6.1 restores Blood Oxygen monitoring for affected U.S. Apple Watch users
  • New system processes blood oxygen data on iPhone instead of watch directly
  • Update only affects Series 9, Series 10, and Ultra 2 models purchased during ban

Apple released iOS 18.6.1 (build number 22G90) on August 14, 2025, specifically targeting the restoration of Blood Oxygen functionality for U.S. Apple Watch Series 9, Series 10, and Ultra 2 users who’ve been without this feature since early 2024. The update represents Apple’s regulatory compliance solution following a U.S. International Trade Commission ban triggered by Masimo’s patent dispute.

This isn’t your typical iOS update. No new features, security patches, or bug fixes—just one targeted fix for a problem that shouldn’t have existed in the first place. The solution requires both iOS 18.6.1 and the companion watchOS 11.6.1 update to function.

How the New Blood Oxygen Experience Actually Works

Your watch collects data, but your iPhone does all the thinking and displaying.

As we reported earlier, he workaround shifts blood oxygen processing from your wrist to your pocket. Your Apple Watch still captures the sensor data, but everything gets shipped to your iPhone for calculation and storage. Results appear exclusively in the Health app’s Respiratory section—you won’t see readings directly on your watch anymore.

Apple describes this as providing “a new Blood Oxygen experience for users in the United States,” which translates to: we found a way around the patent ban by moving the computational heavy lifting. It’s functional, but clunkier than the seamless on-device experience international users still enjoy.

Who Gets This Update and Why It Matters

Only specific U.S. Apple Watch owners affected by the original trade ban qualify.

This update exclusively serves Apple Watch owners who bought Series 9, Series 10, or Ultra 2 models in the U.S. after the initial ITC ban removed Blood Oxygen functionality. If you purchased your watch before the dispute or bought it outside the U.S., you’re unaffected—your blood oxygen monitoring already works normally.

The restoration matters for users who paid full price for health tracking capabilities they couldn’t access. While the iPhone-dependent solution feels like a compromise rather than a victory, it beats having no blood oxygen monitoring at all.

You can grab both updates through your device settings. Just remember: this workaround represents Apple navigating patent law, not advancing health technology.

Share this

At Gadget Review, our guides, reviews, and news are driven by thorough human expertise and use our Trust Rating system and the True Score. AI assists in refining our editorial process, ensuring that every article is engaging, clear and succinct. See how we write our content here →